Although cisplatin is a promising anti-cancer agent,multifactorial resistance,serious side effects,and general toxicity have limited the use of cisplatin in cancer chemotherapy [1].Therefore,less toxic and more effective metal-based anti-cancer compounds have been extensively sought and developed,and drug delivery systems have been exploited to improve the selectivity of anti-cancer drugs and decrease their side effects [2,3].